KSENIYA STOCKHAMMER: Open Payments
NPI 1588230767 · PALM COAST, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,256 in 49 payments from 13 companies in 2025. Trend: 2023 $2,667 · 2024 $2,222 · 2025 $1,256
Food & beverage: $1,213Education: $43
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $206 |
| ABBVIE INC. | 6 | $195 |
| UCB, Inc. | 3 | $175 |
| GENZYME CORPORATION | 5 | $154 |
| Janssen Biotech, Inc. | 9 | $145 |
| Regeneron Healthcare Solutions, Inc. | 4 | $95 |
| Galderma Laboratories, L.P. | 1 | $76 |
| Organogenesis Inc. | 3 | $52 |
| Incyte Corporation | 2 | $48 |
| Amgen Inc. | 2 | $39 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, TREMFYA, COSENTYX, NEMLUVIO, NOVACHOR, OPZELURA.
Industry payments across FL — which companies pay providers there.
